In Depth 10 Dec 2025 Promising cure for COPD: Is a breakthrough treatment within reach? Find out whether a promising cure for COPD is within reach, after recent advancements in treatments and research around the disease. December 10, 2025 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 9 Dec 2025 When AI isn’t enough: How physics is shaping the next wave of drug discovery Discover what the next wave of AI-assisted drug discovery looks like and how it can help biotech – the AI and physics combo. December 9, 2025 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 5 Dec 2025 The biggest biotech funding rounds in November 2025 The companies Cogent Biosciences, Braveheart Bio, and AAVantgarde bagged the biggest biotech funding rounds overall in November 2025. December 5, 2025 - 4 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 3 Dec 2025 Boehringer Ingelheim’s pipeline activity: A busy year of dealmaking for the German pharma in 2025 Discover Boehringer Ingelheim’s pipeline focus areas and how its dealmaking in 2025 has expanded its therapeutic arsenal. December 3, 2025 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 28 Nov 2025 Research Triangle Park: A closer look at North Carolina’s burgeoning biotech hub Discover what makes North Carolina’s Research Triangle Park’s life sciences and biotech ecosystem so successful. November 28, 2025 - 6 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 26 Nov 2025 Beyond GLP-1s: is there a new wave of metabolic disease treatments? A new wave of metabolic disease treatments beyond GLP-1 agonists is emerging to address the unmet needs of patients. November 26, 2025 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 18 Nov 2025 Twice the punch: The emergence of dual-payload antibody and peptide drug conjugates Discover the emergence of dual-payload ADCs and PDCs, which could mark a significant evolution in targeted therapeutics. November 18, 2025 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 5 Nov 2025 Novo Nordisk’s pipeline plan: How the pharma giant is refocusing amid major restructuring Discover how Novo Nordisk’s pipeline is being restructured to refocus its efforts on high-growth areas like diabetes and obesity. November 5, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 4 Nov 2025 The biggest biotech funding rounds in October 2025 The companies Kailera Therapeutics, Summit Therapeutics, and Tubulis bagged the biggest biotech funding rounds overall in October 2025. November 4, 2025 - 5 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 31 Oct 2025 Spooky science: lab-grown breakthroughs or nightmares? From growing mini-organs to reviving the dodo and gene-editing embryos, boundaries between sci-fi and today’s advances are dissolving fast. October 31, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 29 Oct 2025 Parkinson’s disease: biotech’s pursuit for more therapies Rigorous research aims to boost therapeutic options for people with Parkinson’s disease. What do biotechs have in store? October 29, 2025 - 12 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 22 Oct 2025 PCSK9’s second act: From antibodies to gene editing With Eli Lilly’s recent acquisition of Verve Therapeutics and its PCSK9 candidate, delve into what the target represents. October 22, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email